Multiple endocrine neoplasia type 2: Difference between revisions
No edit summary |
No edit summary |
||
Line 26: | Line 26: | ||
==Diagnosis== | ==Diagnosis== | ||
[[Multiple endocrine neoplasia type 2 history and symptoms|History & Symptoms]] | [[Multiple endocrine neoplasia type 2 physical examination|Physical Examination]] | [[Multiple endocrine neoplasia type 2 laboratory tests|Laboratory Findings]] | [[Multiple endocrine neoplasia type 2 CT|CT]] | [[Multiple endocrine neoplasia type 2 MRI|MRI]] | [[Multiple endocrine neoplasia type 2 echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Multiple endocrine neoplasia type 2 other imaging findings|Other Imaging Findings]] | [[Multiple endocrine neoplasia type 2 other diagnostic studies|Other Diagnostic Studies]] | [[Multiple endocrine neoplasia type 2 diagnostic criteria|Diagnostic Criteria]] | [[Multiple endocrine neoplasia type 2 history and symptoms|History & Symptoms]] | [[Multiple endocrine neoplasia type 2 physical examination|Physical Examination]] | [[Multiple endocrine neoplasia type 2 laboratory tests|Laboratory Findings]] | [[Multiple endocrine neoplasia type 2 CT|CT]] | [[Multiple endocrine neoplasia type 2 MRI|MRI]] | [[Multiple endocrine neoplasia type 2 echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Multiple endocrine neoplasia type 2 other imaging findings|Other Imaging Findings]] | [[Multiple endocrine neoplasia type 2 other diagnostic studies|Other Diagnostic Studies]] | ||
==Treatment== | ==Treatment== |
Revision as of 02:46, 5 October 2015
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Synonyms and keywords: Familial endocrine adenomatosis type 2; Familial endocrine adenomatosis type 2a; Familial endocrine adenomatosis type 2b; Familial chromaffinomatosis type 2; Familial medullary thyroid carcinoma; Multiple endocrine adenomatosis type 2; Multiple endocrine adenomatosis type 2a; Multiple endocrine adenomatosis type 2b; Multiple endocrine neoplasia syndrome type 2; Multiple endocrine neoplasia syndrome type 2a; Multiple endocrine neoplasia syndrome type 2b; MEN type 2; MEN type 2a; MEN type 2b; MEN 2 syndrome; MEN type II; MEN type IIa; MEN type IIb; MEA type 2; MEA type 2a; MEA type 2b; Multiple endocrine neoplasms type 2; Multiple endocrine neoplasms type 2a; Multiple endocrine neoplasms type 2b; Multiple neuroma syndrome type 2; Multiple neuroma syndrome type 2a; Multiple neuroma syndrome type 2b; PTC syndrome; Sipple's syndrome; Pheochromocytoma and amyloid producing medullary thyroid carcinoma; Wagenmann-Froboese syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Multiple endocrine neoplasia type 2 from other Diseases
Epidemiology & Demographics
Risk Factors
Screening
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Criteria | History & Symptoms | Physical Examination | Laboratory Findings | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies